1. Home
  2. NURO vs SNGX Comparison

NURO vs SNGX Comparison

Compare NURO & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • SNGX
  • Stock Information
  • Founded
  • NURO 1996
  • SNGX 1987
  • Country
  • NURO United States
  • SNGX United States
  • Employees
  • NURO N/A
  • SNGX N/A
  • Industry
  • NURO Medical/Dental Instruments
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NURO Health Care
  • SNGX Health Care
  • Exchange
  • NURO Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • NURO 8.2M
  • SNGX 7.4M
  • IPO Year
  • NURO N/A
  • SNGX 1987
  • Fundamental
  • Price
  • NURO $4.38
  • SNGX $2.42
  • Analyst Decision
  • NURO
  • SNGX
  • Analyst Count
  • NURO 0
  • SNGX 0
  • Target Price
  • NURO N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • NURO 21.5K
  • SNGX 49.5K
  • Earning Date
  • NURO 02-24-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • NURO N/A
  • SNGX N/A
  • EPS Growth
  • NURO N/A
  • SNGX N/A
  • EPS
  • NURO N/A
  • SNGX N/A
  • Revenue
  • NURO $3,767,764.00
  • SNGX $364,183.00
  • Revenue This Year
  • NURO N/A
  • SNGX N/A
  • Revenue Next Year
  • NURO N/A
  • SNGX $76.64
  • P/E Ratio
  • NURO N/A
  • SNGX N/A
  • Revenue Growth
  • NURO N/A
  • SNGX N/A
  • 52 Week Low
  • NURO $2.66
  • SNGX $1.83
  • 52 Week High
  • NURO $4.73
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • NURO 64.71
  • SNGX 46.88
  • Support Level
  • NURO $4.16
  • SNGX $2.25
  • Resistance Level
  • NURO $4.39
  • SNGX $2.60
  • Average True Range (ATR)
  • NURO 0.06
  • SNGX 0.15
  • MACD
  • NURO 0.00
  • SNGX 0.04
  • Stochastic Oscillator
  • NURO 84.04
  • SNGX 68.18

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: